PS-2020a / part16
.pdf
|
DICOM PS3.16 2020a - Content Mapping Resource |
Page 1191 |
|
Code Value |
Code Meaning |
Definition |
Notes |
111534 Role of person reporting |
Thefunctionoftheindividualwhoisreportinginformation |
|
|
|
|
onapatient,whichcouldbeaspecifichealthcarerelated |
|
|
|
profession,thepatienthim/herself,orarelativeorfriend. |
|
111535 |
DateTime problem observed |
The date and time that a symptom was noted. |
|
111536 DateTime of last evaluation |
The date and time of the most recent evaluation of an |
|
|
|
|
indicated problem. |
|
111537 FamilyMemberwithRiskFactorApatient'sbiologicalrelativewhoexhibitsahealthfactor |
|
||
|
|
that may indicate an increase in the patient's chances of |
|
|
|
developing a particular disease or medical problem. |
|
111538 |
Age at Occurrence |
The age at which an individual experienced a specific |
|
|
|
event, such as breast cancer. |
|
111539 |
Menopausal phase |
The current stage of an individual in her gynecological |
|
|
|
development. |
|
111540 |
Side of Family |
An indicator of paternal or maternal relationship. |
|
111541 |
Maternal |
Relating to biological female parentage. |
|
111542 |
Unspecified gynecological |
A gynecological hormone for which the specific type is |
|
|
hormone |
not specified. E.g., contraceptive, estrogen, Tamoxifen. |
|
111543 |
Breast feeding history |
An indicator of whether or not a patient ever provided |
|
|
|
breast milk to her offspring. |
|
111544 Average breast feeding periodTheaveragelengthoftimethatapatientprovidedbreast |
|
||
|
|
milk to her offspring. |
|
111545 |
Substance Use History |
Information regarding usage by the patient of certain |
|
|
|
legal or illicit substances. |
|
111546 |
Used Substance Type |
Aclassificationofasubstance,suchasalcoholoralegal |
|
|
|
or illicit drug. |
|
111547 |
EnvironmentalExposureHistoryInformation regarding exposure of the patient to |
|
|
|
|
potentially harmful environmental factors. |
|
111548 |
Environmental Factor |
A classification of a potentially harmful substance or gas |
|
|
|
in a subject's environment, such as asbestos, lead, or |
|
|
|
carcinogens. |
|
111549 |
Previous Reports |
Previous Structured Reports that could have relevant |
|
|
|
information for a current imaging service request. |
|
111550 Personal breast cancer historyAn indication that a patient has had a previous |
|
||
|
|
malignancy of the breast. |
|
111551 |
History of endometrial cancer Indicates a previous occurrence of cancer of the lining |
|
|
|
|
of the uterus. |
|
111552 History of ovarian cancer |
Indicates a previous occurrence of cancer of the lining |
|
|
|
|
of the ovary. |
|
111553 History of high risk lesion on |
Indicates a prior diagnosis of pre-cancerous cells or |
|
|
|
previous biopsy |
tissue removed for pathologic evaluation. |
|
111554 |
Post menopausal patient |
Afemalepatientwhosemenstrualperiodshaveceased. |
|
111555 Late child bearing (after 30) |
A female patient whose first child was born after the |
|
|
|
|
patient was 30 years old. |
|
111556 BRCA1 breast cancer gene |
The first level genetic marker indicating risk for breast |
|
|
|
|
cancer. |
|
111557 BRCA2 breast cancer gene |
Thesecondlevelgeneticmarkerindicatingriskforbreast |
|
|
|
|
cancer. |
|
- Standard -
Page 1192 |
DICOM PS3.16 2020a - Content Mapping Resource |
|
|
Code Value |
Code Meaning |
Definition |
Notes |
111558 |
BRCA3 breast cancer gene |
The third level genetic marker indicating risk for breast |
|
|
|
cancer. |
|
111559 Weak family history of breast cancer
Apatient'sbiologicalaunt,grandmother,orfemalecousin was diagnosed with breast cancer. Definition from BI-RADS®.
111560 Intermediate family history of Apatient'sbiologicalmotherorsisterwasdiagnosedwith breast cancer breast cancer after they had gone through menopause.
Definition from BI-RADS®.
111561 Very strong family history of breast cancer
Apatient'sbiologicalmotherorsisterwasdiagnosedwith breastcancerbeforetheyhadgonethroughmenopause, or more than one of the patient's first-degree relatives (biological mother or sister) were diagnosed with breast cancer after they had gone through menopause. Definition from BI-RADS®.
111562 FamilyhistoryofprostatecancerPreviousdiagnosisofamalignancyoftheprostategland
|
|
in a biological relative. |
111563 |
Family history unknown |
The health record of a patient's biological relatives is not |
|
|
known. |
111564 |
Nipple discharge cytology |
The study of cells obtained from fluid emitted from the |
|
|
breast. |
111565 |
Uterine malformations |
A developmental abnormality resulting in an abnormal |
|
|
shape of the uterus. |
111566 |
Spontaneous Abortion |
Anaturallyoccurringprematureexpulsionfromtheuterus |
|
|
oftheproductsofconception-theembryooranonviable |
|
|
fetus. |
111567 |
Gynecologic condition |
Anailment/abnormalityorstateofthefemalereproductive |
|
|
tract. |
111568 |
Gynecologic surgery |
A surgical operation performed on any portion of the |
|
|
female reproductive tract. |
111569 Previous LBW or IUGR birth |
Prior pregnancy with a low birth weight baby or a fetus |
|
|
|
with Intrauterine Growth Restriction or Retardation. |
111570 |
Previous fetal |
Historyofatleastonepriorpregnancywithfetalanatomic |
|
malformation/syndrome |
abnormality(s). |
111571 Previous RH negative or bloodHistory of delivering a Rhesis Isoimmunization affected
|
dyscrasia at birth |
child(ren) or a child(ren) with another blood disorder. |
111572 History of multiple fetuses |
History of at least one pregnancy that contained more |
|
|
|
than one fetus. E.g., twins, triplets, etc.. |
111573 |
Current pregnancy, known or At least one fetus of this pregnancy has an anatomic |
|
|
suspected |
abnormality(s) that is known to exist, or a "marker" is |
|
malformations/syndromes |
presentthatsuggeststheabnormality(s)maybepresent. |
111574 |
Family history, fetal |
Biological relatives have previously conceived a fetus |
|
malformation/syndrome |
with an anatomic abnormality(s). |
111575 |
High |
A subjective descriptor for an elevated amount of |
|
|
exposure, use, or dosage, incurring high risk of adverse |
|
|
effects. |
111576 |
Medium |
A subjective descriptor for a moderate amount of |
|
|
exposure, use, or dosage, incurring medium risk of |
|
|
adverse effects. |
111577 |
Low |
Asubjectivedescriptorforalimitedamountofexposure, |
|
|
use, or dosage, incurring low risk of adverse effects. |
- Standard -
|
DICOM PS3.16 2020a - Content Mapping Resource |
Page 1193 |
|
Code Value |
Code Meaning |
Definition |
Notes |
111578 |
Dose frequency |
A measurement of the rate of occurrence of which a |
|
|
|
patient takes a certain medication. |
|
111579 |
Rate of exposure |
Thequantityperunitoftimethatapatientwasorisbeing |
|
|
|
exposed to an environmental irritant. |
|
111580 |
Volume of use |
The quantity per unit of time that a medication or |
|
|
|
substance was or is being used. |
|
111581 |
Relative dose amount |
A qualitative descriptor for the amount of a medication |
|
|
|
that was or is being taken. |
|
111582 |
Relative amount of exposure |
A qualitative descriptor for the amount of present or past |
|
|
|
exposure to an environmental irritant. |
|
111583 |
Relative amount of use |
A qualitative descriptor for the amount of a medication |
|
|
|
or substance that was or is being used. |
|
111584 |
Relative dose frequency |
A qualitative descriptor for the frequency with which a |
|
|
|
medication was or is being taken. |
|
111585 |
Relative frequency of exposureA qualitative descriptor for the frequency of present or |
|
|
|
|
past exposure to an environmental irritant. |
|
111586 |
Relative frequency of use |
A qualitative descriptor for the frequency with which a |
|
|
|
medication or substance was or is being used. |
|
111587 |
No known exposure |
Patient is not known to have been exposed to or used |
|
|
|
the substance or medication. |
|
111590 |
Recall for technical reasons |
Patient returns for additional images to improve the |
|
|
|
quality of the most recent exam. |
|
111591 |
Recall for imaging findings |
Patient returns for additional images to clarify findings |
|
|
|
from the most recent exam. |
|
111592 |
Recall for patient symptoms/ |
Patientreturnsforadditionalimagestoclarifysymptoms |
|
|
clinical findings |
or signs reported by the patient or a healthcare |
|
|
|
professional at the time of the most recent exam. |
|
111593 |
LBW or IUGR |
Number of births with low birth weight or intrauterine |
|
|
|
growth restriction. |
|
111601 |
Green filter |
Filter that transmits green light while blocking the otherRetired. Replaced by |
|
|
|
colors, typically centered at 510-540 nm |
(445465004, SCT, "Green |
|
|
|
optical filter") |
111602 |
Red filter |
Filter that transmits red light while blocking the other |
Retired. Replaced by |
|
|
colors, typically centered at 630-680 nm |
(445279009, SCT, "Red |
|
|
|
optical filter") |
111603 |
Blue filter |
Filter that transmits blue while blocking the other colors,Retired. Replaced by |
|
|
|
typically centered at 460-480 nm |
(445084008, SCT, "Blue |
|
|
|
optical filter") |
111604 |
Yellow-green filter |
A filter of 560nm that is used for retinal imaging and canRetired. Replaced by |
|
|
|
provide good contrast and good visibility of the retinal (445340000, SCT, |
|
|
|
vasculature |
"Yellow-green optical filter") |
111605 |
Blue-green filter |
A filter of 490nm that is used for retinal imaging becauseRetired. Replaced by |
|
|
|
of excessive scattering of some retinal structures at very(422915004, SCT, |
|
|
|
short wavelengths |
"Blue-green optical filter") |
111606 |
Infrared filter |
Filter that transmits the infrared spectrum, which is lightRetired. Replaced by |
|
|
|
thatliesoutsideofthevisiblespectrum,withwavelengths(445169002, SCT, "Infrared |
|
|
|
longer than those of red light, while blocking visible lightoptical filter") |
|
111607 |
Polarizing filter |
Afilterthatreducesreflectionsfromnon-metallicsurfacesRetired. Replaced by |
|
|
|
such as glass or water by blocking light waves that are(445391002,SCT,"Polarizing |
|
|
|
vibrating at selected angles to the filter. |
optical filter") |
- Standard -
Page 1194 |
DICOM PS3.16 2020a - Content Mapping Resource |
|
|
Code Value |
Code Meaning |
Definition |
Notes |
111609 |
No filter |
No filter used. |
|
111621 |
Field 1 for Joslin 3 field |
Joslin NM-1 is a 45 degree field focused centrally |
|
|
|
betweenthetemporalmarginofopticdiscandthecenter |
|
|
|
of the macula: Center the camera on the papillomacular |
|
|
|
bundlemidwaybetweenthetemporalmarginoftheoptic |
|
|
|
disc and the center of the macula. The horizontal |
|
|
|
centerline of the image should pass directly through the |
|
|
|
center of the disc. |
|
111622 |
Field 2 for Joslin 3 field |
Joslin NM-2 is a 45 degree field focused superior |
|
|
|
temporal to the optic disc: Center the camera laterally |
|
|
|
approximately one-half disc diameter temporal to the |
|
|
|
center of the macula. The lower edge of the field is |
|
|
|
tangent to a horizontal line passing through the upper |
|
|
|
edge of the optic disc. The image is taken temporal to |
|
|
|
the macula but includes more retinal nasal and superior |
|
|
|
to the macula than standard field 2. |
|
111623 |
Field 3 for Joslin 3 field |
Joslin NM-3 is a 45 degree field focused nasal to the |
|
|
|
optic disc: This field is nasal to the optic disc and may |
|
|
|
include part of the optic disc. The horizontal centerline |
|
|
|
of the image should pass tangent to the lower edge of |
|
|
|
the optic disc. |
|
111625 |
Diffuse direct illumination |
A broad or "soft" light supplied from a single source. |
|
111626 |
Scheimpflug Camera |
A slit reflected light microscope, which has the ability to |
|
|
|
form an image of the back scattered light from the eye |
|
|
|
in a sagittal plane. Scheimpflug cameras are able to |
|
|
|
achieve a wide depth of focus by employing the |
|
|
|
"Sheimpflug principle" where the lens and image planes |
|
|
|
are not parallel with each other. Rotating Sheimplug |
|
|
|
camerasareabletogeneratethree-dimensionalimages |
|
|
|
and calculate measurements of the anterior chamber of |
|
|
|
the eye. |
|
111627 |
Scotopic light |
Lighting condition approximately 0.04 lux. |
|
111628 |
Mesopic light |
Lighting condition approximately 4 lux. |
|
111629 |
Photopic light |
Lighting condition approximately 40 lux. |
|
111630 |
Dynamic light |
Acquisition preceded by intense light. |
|
111631 |
Average Glandular Dose |
Calculated from values of entrance exposure in air, the |
|
|
|
X-Ray beam quality (half-value layer), and compressed |
|
|
|
breast thickness, is the energy deposited per unit mass |
|
|
|
ofglandulartissueaveragedoveralltheglandulartissue |
|
|
|
in the breast. |
|
111632 |
Anode Target Material |
The primary material in the anode of an X-Ray source. |
|
111633 |
Compression Thickness |
The average thickness of the body part examined when |
|
|
|
compressed, if compression has been applied during |
|
|
|
X-Ray exposure. |
|
111634 |
Half Value Layer |
Thickness of Aluminum required to reduce the X-Ray |
|
|
|
output at the patient entrance surface by a factor of two. |
|
111635 |
X-Ray Grid |
Ananti-scatterdevicebasedonradiationabsorbingstrips |
|
|
|
above the detector. E.g., in the patient support. |
|
111636 |
Entrance Exposure at RP |
Exposure measurement in air at the reference point that |
|
|
|
doesnotincludebackscatter,accordingtoMQCM1999. |
|
- Standard -
|
DICOM PS3.16 2020a - Content Mapping Resource |
Page 1195 |
|
Code Value |
Code Meaning |
Definition |
Notes |
111637 AccumulatedAverageGlandularAverage Glandular Dose to a single breast accumulated |
|
||
|
Dose |
over multiple images. |
|
111638 |
Patient Equivalent Thickness |
Value of the control variable used to parametrize the |
|
|
|
Automatic Exposure Control (AEC) closed loop. E.g., |
|
|
|
"Water Value". |
|
111641 |
Fixed grid |
An X-Ray Grid that does not move during exposure. |
|
111642 |
Focused grid |
An X-Ray Grid with radiation absorbing strips that are |
|
|
|
focused toward the focal spot, to eliminate grid cutoff. |
|
111643 |
Reciprocating grid |
AnX-RayGridthatisdesignedtomoveduringexposure, |
|
|
|
to eliminate the appearance of grid lines on the image. |
|
111644 |
Parallel grid |
An X-Ray Grid with radiation absorbing strips that are |
|
|
|
parallel to each other and that is used only with long |
|
|
|
source to image distances. |
|
111645 |
Crossed grid |
An X-Ray Grid with crossed radiation absorbing strips |
|
|
|
used for more complete cleanup of scatter radiation. |
|
111646 |
No grid |
No X-Ray Grid was used due to low scatter conditions. |
|
111647 |
Compression Force |
The compression force applied to the body part during |
|
|
|
exposure. |
|
111648 |
Compression Pressure |
The average compression pressure applied to the body |
|
|
|
part during exposure. |
|
111649 |
Compression Contact Area |
Theareaofthebodyparttowhichcompressionhasbeen |
|
|
|
applied during exposure. |
|
111671 Spectacle Prescription ReportThe spectacle prescription for a patient. |
|
||
111672 |
Add Near |
Refractivemeasurementsoftheeyetocorrectforinability |
|
|
|
to focus at near while wearing the distance prescription. |
|
111673 |
Add Intermediate |
Refractivemeasurementsoftheeyetocorrectforinability |
|
|
|
to focus at intermediate distance while wearing the |
|
|
|
distance prescription. |
|
111674 |
Add Other |
Refractivemeasurementsoftheeyetocorrectforinability |
|
|
|
to focus at the specified distance while wearing the |
|
|
|
distance prescription. |
|
111675 |
Horizontal Prism Power |
The power of a prism to bend light in the horizontal |
|
|
|
direction, in prism diopters. |
|
111676 |
Horizontal Prism Base |
Direction of the base of a horizontal prism -- either in |
|
|
|
(toward the nose), or out (away from the nose). |
|
111677 |
Vertical Prism Power |
Thepowerofaprismtobendlightintheverticaldirection, |
|
|
|
in prism diopters. |
|
111678 |
Vertical Prism Base |
Direction of the base of a vertical prism -- either up, or |
|
|
|
down. |
|
111679 |
Distance Pupillary Distance |
Distance in mm between the pupils when the patient's |
|
|
|
object of regard is in the distance. |
|
111680 |
Near Pupillary Distance |
Distance in mm between the pupils when the patient's |
|
|
|
object of regard is at near. |
|
111681 |
SMILE |
Small Incision Lenticule Extraction. Refractive surgery |
|
|
|
procedure where a thin lenticule is cleaved from the |
|
|
|
corneal stroma using a femtosecond laser and then |
|
|
|
extracted through a small incision in the corneal |
|
|
|
periphery. |
|
- Standard -
Page 1196 |
DICOM PS3.16 2020a - Content Mapping Resource |
|
|
Code Value |
Code Meaning |
Definition |
Notes |
111685 |
Autorefraction Visual Acuity |
A patient's vision with the correction measured by an |
|
|
|
autorefractor in place. |
|
111686 |
Habitual Visual Acuity |
A patient's vision with whichever vision correction the |
|
|
|
patient customarily wears. |
|
111687 |
Prescription Visual Acuity |
A patient's vision with the final spectacle prescription in |
|
|
|
place. |
|
111688 |
Right Eye Rx |
The spectacle prescription for the right eye. |
|
111689 |
Left Eye Rx |
The spectacle prescription for the left eye. |
|
111690 Macular Grid Thickness and |
Amaculargridthicknessandvolumereportforapatient. |
|
|
|
Volume Report |
The macular grid is an analytic tool described in PS3.1. |
|
111691 Number of Images Used for |
Number of images used for the macular grid |
|
|
|
Macular Measurements |
measurement. |
|
111692 Number of Samples Used per Number of samples used per Image for analysis. |
|
||
|
Image |
|
|
111693 |
Analysis Quality Rating |
A numeric rating of the quality of the entire analysis with |
|
|
|
respect to grading and diagnostic purposes. |
|
|
|
Higher numbers indicate greater quality. |
|
111694 Image Set Quality Rating |
Anumericratingofthequalityofanentireimagesetwith |
|
|
|
|
respect to grading and diagnostic purposes. |
|
|
|
Higher numbers indicate greater quality. |
|
111695 Interfering Tears or Drops |
Tear film or drops affecting test quality. |
|
|
111696 Visual Fixation Quality During The assessment of the centricity and persistence of the |
|
||
|
Acquisition |
visual fixation (direction of gaze) during the acquisition. |
|
111697 Visual Fixation Quality ProblemThe reason why the patient's visual fixation was not |
|
||
|
|
steady or was indeterminate. |
|
111698 |
Ophthalmic Macular Grid |
The reason why the macular grid measurements may |
|
|
Problem |
be questionable. |
|
111700 Specimen Container Identifier Identifierofcontainer(box,block,microscopeslide,etc.) |
|
||
|
|
for the specimen under observation. |
|
111701 |
Processing type |
Type of processing that tissue specimen underwent. |
|
111702 |
DateTime of processing |
Date and time of processing step. |
|
111703 |
Processing step description |
Descriptionoftheindividualstepinthetissueprocessing |
|
|
|
sequence. |
|
111704 |
Sampling Method |
Method of sampling used to derive specimen from its |
|
|
|
parent. |
|
111705 |
Parent Specimen Identifier |
Identifier of the parent specimen that gave rise to the |
|
|
|
current specimen. |
|
111706 Issuer of Parent Specimen |
Assigning authority for parent specimen's identifier. |
|
|
|
Identifier |
|
|
111707 |
Parent specimen type |
Parentspecimentypethatgaverisetocurrentspecimen. |
|
111708 Position Frame of Reference |
Description of coordinate system and origin reference |
|
|
|
|
pointonparentspecimen,orparentspecimencontainer, |
|
|
|
or image used for localizing the sampling site or location |
|
|
|
within container or image. |
|
111709 Location of sampling site |
Reference to image of parent specimen localizing the |
|
|
|
|
samplingsite;mayincludereferencedPresentationState |
|
|
|
object. |
|
- Standard -
|
DICOM PS3.16 2020a - Content Mapping Resource |
Page 1197 |
|
Code Value |
Code Meaning |
Definition |
Notes |
111710 Location of sampling site X |
Location of sampling site of specimen (nominal center) |
|
|
|
offset |
relative to the Position Frame of Reference. |
|
111711 Location of sampling site Y |
Location of sampling site of specimen (nominal center) |
|
|
|
offset |
relative to the Position Frame of Reference. |
|
111712 |
LocationofsamplingsiteZoffsetLocation of sampling site of specimen (nominal center) |
|
|
|
|
relative to the Position Frame of Reference. |
|
111718 |
Location of Specimen |
Descriptionofspecimenlocation,eitherinabsoluteterms |
|
|
|
or relative to the Position Frame of Reference. |
|
111719 Location of Specimen X offsetLocation of specimen (nominal center) relative to the Position Frame of Reference in the X dimension.
111720 Location of Specimen Y offsetLocation of specimen (nominal center) relative to the Position Frame of Reference in the Y dimension.
111721 Location of Specimen Z offsetLocation of specimen (nominal center) relative to the Position Frame of Reference in the Z dimension.
111723 |
Visual Marking of Specimen |
Description of visual distinguishing identifiers. E.g., ink, |
|
|
or a particular shape of the specimen. |
111724 |
Issuer of Specimen Identifier |
Assigning authority for specimen identifier. |
111726 Dissection with entire specimenDissectionofspecimenwithsubmissionofallitssections submission for further processing or examination.
111727 Dissection with representativeDissectionofspecimenwithsubmissionofrepresentative
|
sections submission |
sections for further processing or examination. |
111729 |
Specimen storage |
A workflow step, during which tissue specimens are |
|
|
stored in a climate-controlled environment. |
111741 |
Transmission illumination |
Transmission illumination method for specimen |
|
|
microscopy. |
111742 |
Reflection illumination |
Reflectionilluminationmethodforspecimenmicroscopy. |
111743 |
Epifluorescence illumination |
Epifluorescence illumination method for specimen |
|
|
microscopy. |
111744 |
Brightfield illumination |
Brightfieldilluminationmethodforspecimenmicroscopy. |
111745 |
Darkfield illumination |
Darkfield illumination method for specimen microscopy. |
111746 |
Oblique illumination |
Oblique illumination method for specimen microscopy. |
111747 |
Phase contrast illumination |
Phase contrast illumination method for specimen |
|
|
microscopy. |
111748 |
DifferentialinterferencecontrastDifferential interference contrast method for specimen |
|
|
|
microscopy. |
111749 |
Total internal reflection |
Total internal reflection fluorescence method for |
|
fluorescence |
specimen microscopy. |
111750 |
Ultrasound Contact |
A method of obtaining ophthalmic axial measurements |
|
|
that uses ultrasound, and that requires applanation of |
|
|
the cornea. |
111751 |
Ultrasound Immersion |
A method of obtaining ophthalmic axial measurements |
|
|
that uses ultrasound, and that requires immersion of the |
|
|
patient's eye in fluid as he lies in a supine position. |
111752 |
Optical |
A method of obtaining ophthalmic axial measurements |
|
|
that uses light. |
111753 |
Manual Keratometry |
Measurements taken of the corneal curvature using a |
|
|
manual keratometer. |
- Standard -
Page 1198 |
DICOM PS3.16 2020a - Content Mapping Resource |
|
|
Code Value |
Code Meaning |
Definition |
Notes |
111754 |
Auto Keratometry |
Measurements taken of the corneal curvature using an |
|
|
|
automated keratometer. |
|
111755 |
Simulated Keratometry |
Simulated Keratometry measurements derived from |
|
|
|
corneal topography. |
|
111756 |
Equivalent K-reading |
Corneal power measurements using Scheimpflug |
|
|
|
camera. |
|
111757 |
Keratometry Measurements |
Keratometry Measurements DICOM SOP Instance. |
|
|
SOP Instance |
|
|
111758 |
Total Cornea Power |
Method of determining the total cornea power from |
|
|
Measurement Method |
measuring the curvature of both anterior and posterior |
|
|
|
surface of the cornea. |
|
111759 |
Posterior Cornea Surface |
Method of measuring the curvature of posterior surface |
|
|
Measurement Method |
of the cornea and determining its refractive power. |
|
111760 |
Haigis |
The Haigis IOL calculation formula. |
|
|
|
Haigis W, Lege B, Miller N, Schneider B. Comparison of |
|
|
|
immersion ultrasound biometry and partial coherence |
|
|
|
interferometry for intraocular lens calculation according |
|
|
|
to Haigis. Graefes Arch Clin Exp Ophthalmol |
|
|
|
2000;238:765-73. |
|
111761 |
Haigis-L |
The Haigis-L IOL calculation formula. |
|
|
|
Haigis W. Intraocular lens calculation after refractive |
|
|
|
surgery for myopia: Haigis-L formula. J Cataract Refract |
|
|
|
Surg. 2008 Oct;34(10):1658-63. |
|
111762 |
Holladay 1 |
The Holladay 1 IOL calculation formula. |
|
|
|
Holladay JT, Prager TC, Chandler TY, Musgrove KH, |
|
|
|
Lewis JW, Ruiz RS. A three-part system for refining |
|
|
|
intraocular lens power calculations. J Cataract Refract |
|
|
|
Surg. 1988; 14:17-24. |
|
111763 |
Holladay 2 |
The Holladay 2 IOL calculation formula. |
|
111764 |
Hoffer Q |
The Hoffer Q IOL calculation formula. Hoffer KJ. The |
|
|
|
Hoffer Q formula: a comparison of theoretic and |
|
|
|
regression formulas. J Cataract Refract Surg |
|
|
|
1993;19:700-12. Errata. J Cataract Refract Surg |
|
|
|
1994;20:677 and 2007;33:2-3. |
|
111765 |
Olsen |
The Olsen IOL calculation formula. Olsen T. Calculation |
|
|
|
of intraocular lens power: a review. Acta Ophthalmol. |
|
|
|
Scand. 2007: 85: 472-485. |
|
111766 |
SRKII |
TheSRKIIIOLcalculationformula.SandersDR,Retzlaff |
|
|
|
J,KraffMC.ComparisonoftheSRKIIformulaandother |
|
|
|
second generation formulas. J Cataract Refract Surg. |
|
|
|
1988 Mar;14(2):136-41. |
|
111767 |
SRK-T |
The SRK-T IOL calculation formula. |
|
|
|
Retzlaff JA, Sanders DR, Kraff MC. Development of the |
|
|
|
SRK/Tintraocularlensimplantpowercalculationformula. |
|
|
|
J Cataract Refract Surg 1990;16:333-40. Erratum |
|
|
|
1990;16:528. |
|
111768 |
ACD Constant |
The "ACD Constant" used in IOL calculation. |
|
111769 |
Haigis a0 |
The "Haigis a0" constant used in IOL calculation. |
|
- Standard -
|
DICOM PS3.16 2020a - Content Mapping Resource |
Page 1199 |
|
Code Value |
Code Meaning |
Definition |
Notes |
111770 |
Haigis a1 |
The "Haigis a1" constant used in IOL calculation. |
|
111771 |
Haigis a2 |
The "Haigis a2" constant used in IOL calculation. |
|
111772 |
Hoffer pACD Constant |
The "Hoffer pACD Constant" used in IOL calculation. |
|
111773 |
Surgeon Factor |
The "Surgeon Factor" constant used in IOL calculation. |
|
111776 Front Of Cornea To Front Of |
Anteriorchamberdepthdefinedasthefrontofthecornea |
|
|
|
Lens |
to the front of the lens. |
|
111777 Back Of Cornea To Front Of |
Anteriorchamberdepthdefinedasthebackofthecornea |
|
|
|
Lens |
to the front of the lens. |
|
111778 Single or Anterior Lens |
Refers to the anterior lens when there are two lenses in |
|
|
|
|
the eye. The distance, in mm, from the anterior surface |
|
|
|
of the lens to the posterior surface of the lens. |
|
111779 |
Posterior Lens |
Refers to the posterior lens when there are two lenses |
|
|
|
intheeye.Thedistance,inmm,fromtheanteriorsurface |
|
|
|
of the lens to the posterior surface of the lens. |
|
111780 MeasurementFromThisDeviceValue obtained from measurements taken by the device |
|
||
|
|
creating this SOP Instance. |
|
111781 |
External Data Source |
Value obtained by data transfer from an external source |
|
|
|
- not from measurements taken by the device providing |
|
|
|
the value. |
|
111782 |
Axial Measurements SOP |
Axial Measurements DICOM SOP Instance. |
|
|
Instance |
|
|
111783 Refractive Measurements SOPRefractive Measurements DICOM SOP Instance. |
|
||
|
Instance |
|
|
111784 Autorefraction Measurements Autorefraction Measurements DICOM SOP Instance. |
|
||
|
SOP Instance |
|
|
111786 |
Standard Deviation of |
StandardDeviationisasimplemeasureofthevariability |
|
|
measurements used |
of data. |
|
111787 Signal to Noise Ratio |
SignaltoNoiseRatioofthedatasamplestakentocreate |
|
|
|
|
a measurement. |
|
111791 |
Spherical projection |
Projection from 2D image pixels to 3D Cartesian |
|
|
|
coordinates based on a spherical mathematical model. |
|
111792 |
Surface contour mapping |
Mapping from 2D image pixels to 3D Cartesian |
|
|
|
coordinates based on measurements of the retinal |
|
|
|
surface. E.g., of the retina, derived via a measurement |
|
|
|
technology such as Optical Coherence Tomography, |
|
|
|
Ultrasound etc. |
|
111800 Visual Field 24-2 Test Pattern Test pattern, nominally covering an area within 24° of fixation. Consists of 54 test points a minimum of 3° from each meridian and placed 6° apart.
The "-2" distinguishes this from another 24° pattern (no longer supported).
111801 Visual Field 10-2 Test Pattern Test pattern, nominally covering an area within 10° of fixation. Consists of 68 test points a minimum of 1° from each meridian and placed 2° apart.
The"-2"inthiscaseindicatesitspointlayouttobesimilar to the 30-2 and 24-2.
- Standard -
Page 1200 |
DICOM PS3.16 2020a - Content Mapping Resource |
|
|
Code Value |
Code Meaning |
Definition |
Notes |
111802 Visual Field 30-2 Test Pattern Test pattern consisting of test point locations within 30° of fixation. Consists of 76 test points a minimum of 3° from each meridian and placed 6° apart.
The "-2" distinguishes this from another 30° pattern (no longer supported).
111803 Visual Field 60-4 Test Pattern Testpatternconsistingof60testpointlocationsbetween 30° and 60° of fixation a minimum of 6° from each meridian and placed 12° apart.
The "-4" distinguishes this from a similar 60° pattern having 4 additional points.
111804 VisualFieldMaculaTestPatternTest pattern consisting of 16 test point locations within 10° of fixation a minimum of 1° from each meridian and placed 2° apart.
111805 Visual Field Central 40 Point |
Test pattern consisting of 40 test point locations within |
Test Pattern |
30° of fixation that spread out radially from fixation. |
111806 Visual Field Central 76 Point |
Test pattern consisting of 76 test point locations within |
Test Pattern |
30° of fixation a minimum of 3° from each meridian and |
|
placed 6° apart. |
111807 Visual Field Peripheral 60 PointTestpatternconsistingof60testpointlocationsbetween |
|
Test Pattern |
30° and 60° of fixation a minimum of 6° from each |
|
meridian and placed 12° apart. |
111808 Visual Field Full Field 81 PointTest pattern consisting of 81 test point locations within Test Pattern 60° of fixation that spread out radially from fixation.
111809 Visual Field Full Field 120 PointTest pattern consisting of 120 test point locations within
Test Pattern |
60° of fixation that spread out radially from fixation, |
|
concentrated in the nasal hemisphere. |
111810 Visual Field G Test Pattern |
Test pattern for Glaucoma and general visual field |
|
assessment with 59 test locations of which 16 test |
|
locations are in the macular area (up to 10° eccentricity) |
|
and where the density of test location is reduced with |
|
eccentricity. The test can be extended with the inclusion |
|
of 14 test locations between 30° and 60° eccentricity, 6 |
|
of which are located at the nasal step. |
111811 Visual Field M Test Pattern |
Testpatternforthemaculararea.Orthogonaltestpattern |
|
with 0.7° spacing within the central 4° of eccentricity and |
|
reduced density of test locations between 4 and 10, 5° |
|
of eccentricity. 81 test locations over all. The test can be |
|
extended to include the test locations of the Visual Field |
|
G Test Pattern between 10, 5° and 60°. |
111812 Visual Field 07 Test Pattern |
Full field test pattern with 48 test locations from 0-30° |
|
and 82 test locations from 30-70°. Reduced test point |
|
density with increased eccentricity. Can be combined |
|
with screening and threshold strategies. |
111813 Visual Field LVC Test Pattern Low Vision Central. Orthogonal off-center test pattern with 6° spacing. 75 test locations within the central 30°. Corresponds with the 32/30-2 excluding the 2 locations at the blind spot, including a macular test location. The LVC is linked with a staircase threshold strategy starting at 0 dB intensity and applies stimulus area V.
- Standard -